Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 1, 2014
Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse modelsZsofia Kovacs, Beat Werner, Anahita Rassi, et al.
Molecular Cancer|January 12, 2007
Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cellsSieta P Rao, Markus P Rechsteiner, Christoph Berger, et al.
Plos One|August 23, 2016
The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and InvasionPatricia Jaaks, Valentina D'Alessandro, Nicole Grob, et al.
Journal of Virology|June 20, 2014
Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivationFlorian Haas, Kazuma Yamauchi, Monika Murat, et al.
Nanomedicine (London, England)|April 28, 2017
Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcomaMaurizio Roveri, Alice Pfohl, Patricia Jaaks, et al.
Virology Journal|June 8, 2006
Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarrayMichele Bernasconi, Christoph Berger, Jürg A Sigrist, et al.
International Journal of Cancer|January 7, 2009
Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1Hendrik Witt, Katarina Hajdin, Kristina Iljin, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2023
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse modelsAndrea Timpanaro, Caroline Piccand, Dzhangar Dzhumashev, et al.
Journal of Virology|December 7, 2007
Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infectionMarkus P Rechsteiner, Christoph Berger, Ludwig Zauner, et al.
Cancers|October 27, 2022
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for RhabdomyosarcomaDzhangar Dzhumashev, Andrea Timpanaro, Safa Ali, et al.
Pageof 5